Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Cash Acquisitions

Gilead Sciences Inc Cash Acquisitions Chart (GILD)

Gilead Sciences Inc annual/quarterly Cash Acquisitions from 2010 to 2020.
  • Gilead Sciences Inc Cash Acquisitions for the quarter ending September 09, 2020 was $-1,000m a 76.10% decrease of -761m year over year
  • Gilead Sciences Inc Cash Acquisitions for the last 12 months ending September 09, 2020 was $-1,553m a 84.61% decrease of -1,314m year over year
  • Gilead Sciences Inc Annual Cash Acquisitions for 2017 was $-10,426m a 96.36% decrease of -10,047m from 2016
  • Gilead Sciences Inc Annual Cash Acquisitions for 2013 was $-379m a -2,736.94% increase of 10,373m from 2012
  • Gilead Sciences Inc Annual Cash Acquisitions for 2012 was $-10,752m a 94.53% decrease of -10,163m from 2011
Other Cash Flow Metrics:
  • Gilead Sciences Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $2,212m a -24.46% decrease of -541m year over year
  • Gilead Sciences Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,592m a -123.19% decrease of -1,962m year over year
  • Gilead Sciences Inc Total Revenue for the quarter ending December 12, 2018 was $5,795m a 12.20% increase of 707m year over year
View Chart On Koyfin

Quarterly GILD Cash Acquisitions Data

09/2020$-1,000m
06/2020$-4,804m
09/2019$-4,012m
06/2019$-239m
12/2017$-10,426m
12/2013$0m
09/2013$0m
06/2013$0m
03/2013$-379m
12/2012$0m

Annual GILD Cash Acquisitions Data

2017$-10,426m
2013$-379m
2012$-10,752m
2011$-589m
2010$-91m